AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
AMARIN CORP PLC\UK
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$11.53+0.21 (+1.86%)
Close on Oct 19, 2026
- Market cap
- $4.80B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
1.0%
5M of 443M shares
Institutional holders
80
21 new, 7 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Sarissa Capital Management LP | 25,743,900 | 6.09% | 13D (active) amendment | Aug 25, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AMRN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Sarissa Capital Management LP | 1,673,395 | 0.38% | $26.67M | – | 15.00% |
| Acadian Asset Management LLC | 720,984 | 0.16% | $11.47K | +84,215 | 0.01% |
| Kynam Capital Management, LP | 532,982 | 0.12% | $8.50M | +60,600 | 0.47% |
| Morgan Stanley | 223,617 | 0.05% | $3.56M | −69,555 | 0.00% |
| Waterfront Wealth Inc. | 213,949 | 0.05% | $3.18M | +10,611 | 0.49% |
| Brooklands Fund Management Ltd | 177,325 | 0.04% | $2.74M | New | 2.14% |
| Eversept Partners, LP | 145,296 | 0.03% | $2.32M | −2,419 | 0.12% |
| Millennium Management LLC | 115,808 | 0.03% | $1.85M | −184,728 | 0.00% |
| Two Sigma Investments, LP | 100,511 | 0.02% | $1.60M | −7,031 | 0.00% |
| Citadel Advisors LLC | 95,364 | 0.02% | $1.52M | +14,789 | 0.00% |
| Bnp Paribas Arbitrage, Snc | 71,813 | 0.02% | $1.14M | −3,690 | 0.00% |
| LCM Capital Management Inc | 51,362 | 0.01% | $818.71K | +7,900 | 0.36% |
| Renaissance Technologies LLC | 48,369 | 0.01% | $771.00K | +29,113 | 0.00% |
| Jane Street Group, LLC | 37,628 | 0.01% | $599.79K | New | 0.00% |
| George Kaiser Family Foundation | 37,207 | 0.01% | $593.08K | New | 0.06% |
| Sei Investments Co | 29,211 | 0.01% | $465.63K | New | 0.00% |
| Susquehanna International Group, Llp | 29,001 | 0.01% | $462.28K | −8,666 | 0.00% |
| State Street Corp | 25,016 | 0.01% | $398.76K | +67 | 0.00% |
| Bleakley Financial Group, LLC | 23,505 | 0.01% | $374.67K | −59 | 0.00% |
| Ameriprise Financial Inc | 18,982 | 0.00% | $302.57K | +766 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 80 | 5M | 1.0% | 21 / 15 | 13 / 7 | 1M | 1M |
| Q1 2026 | 67 | 5M | 1.0% | 6 / 20 | 14 / 19 | 1M | 1M |
| Q4 2025 | 81 | 5M | 1.0% | 10 / 26 | 17 / 18 | 1M | 0M |
| Q3 2025 | 90 | 4M | 0.9% | 12 / 29 | 14 / 9 | 1M | 0M |
| Q2 2025 | 87 | 4M | 0.8% | 83 / 0 | 4 / 6 | 3M | 1M |
| Q1 2025 | 11 | 1M | 0.3% | 11 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of AMRN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Old Westbury Small & Mid Cap Strategies Fund | 58,097 | 0.01% | $828.46K | 0.01% | Jul 31, 2026 |
| State Street(R) SPDR(R) Portfolio Developed World ex-US ETF | 16,644 | 0.00% | $265.31K | 0.00% | Jun 30, 2026 |
| SIT International Equity Fund | 13,654 | 0.00% | $217.64K | 0.01% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 11,771 | 0.00% | $170.56K | 0.00% | May 31, 2026 |
| Voya Multi-Manager International Small Cap Fund | 10,540 | 0.00% | $150.30K | 0.03% | Jul 31, 2026 |
| Nomura Healthcare Fund | 9,500 | 0.00% | $151.43K | 0.02% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) International Small Cap ETF | 7,907 | 0.00% | $126.04K | 0.01% | Jun 30, 2026 |
| Steward Values Enhanced International Fund | 5,897 | 0.00% | $84.09K | 0.02% | Jul 31, 2026 |
| Tiff Multi-Asset Fund | 2,491 | 0.00% | $39.71K | 0.00% | Jun 30, 2026 |
| Blackstone Alternative Multi-Strategy Fund | 685 | 0.00% | $10.92K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Peter L. Fishman | SVP, CFO | 7,774 | 0.00% | Aug 3, 2026 |
| Steven B. Ketchum | EVP, Chief Scientific Officer | 42,680 | 0.01% | Jul 15, 2026 |
| David Paul Keenan | EVP, Chief Operating Officer | 13,470 | 0.00% | Jul 15, 2026 |
| Jonathan Provoost | EVP, Chief Legal Officer | 5,888 | 0.00% | Jul 15, 2026 |
| Aaron Berg | President and CEO | 85,648 | 0.02% | Jun 30, 2026 |
| Patrice Eadon Bonfiglio | Director | 1,239 | 0.00% | Apr 22, 2026 |
| Keith Horn | Director | 1,239 | 0.00% | Apr 21, 2026 |
| Kostas D. Odysseas | Director | 1,239 | 0.00% | Apr 21, 2026 |
| Paul Cohen | Director | 1,239 | 0.00% | Apr 21, 2026 |
| Diane E. Sullivan | Director | 836 | 0.00% | Apr 21, 2026 |
| Louis Sterling III | Director | 5,450 | 0.00% | Apr 21, 2026 |
| Oliver O'Connor | Director | 1,239 | 0.00% | Apr 21, 2026 |
| Mark DiPaolo | Director | 838 | 0.00% | Apr 22, 2025 |
| Michael Torok | Director | 4,850,000 | 1.09% | Apr 11, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Peter L. Fishman SVP, CFO | Aug 1, 2026 | Option exercise | +313 | – | – | 7,774 |
| Peter L. Fishman SVP, CFO | Aug 1, 2026 | Tax withholding | −155 | $14.26 | $2.21K | 7,619 |
| Jonathan Provoost EVP, Chief Legal Officer | Jul 1, 2026 | Option exercise | +3,688 | – | – | 5,888 |
| Jonathan Provoost EVP, Chief Legal Officer | Jul 1, 2026 | Tax withholding | −1,264 | $15.94 | $20.15K | 4,624 |
| David Paul Keenan EVP, Chief Operating Officer | Jul 1, 2026 | Tax withholding | −1,926 | $15.94 | $30.70K | 13,470 |
| David Paul Keenan EVP, Chief Operating Officer | Jul 1, 2026 | Option exercise | +3,688 | – | – | 15,396 |
| Peter L. Fishman SVP, CFO | Jul 1, 2026 | Tax withholding | −1,206 | $15.94 | $19.22K | 7,461 |
| Peter L. Fishman SVP, CFO | Jul 1, 2026 | Option exercise | +2,447 | – | – | 8,667 |
| Steven B. Ketchum EVP, Chief Scientific Officer | Jul 1, 2026 | Tax withholding | −1,887 | $15.94 | $30.08K | 42,680 |
| Steven B. Ketchum EVP, Chief Scientific Officer | Jul 1, 2026 | Option exercise | +3,688 | – | – | 44,567 |
| Aaron Berg President and CEO | Jun 26, 2026 | Tax withholding | −3,197 | $16.35 | $52.27K | 85,648 |
| Aaron Berg President and CEO | Jun 26, 2026 | Option exercise | +6,250 | – | – | 88,845 |
| Patrice Eadon Bonfiglio Director | Apr 18, 2026 | Option exercise | +838 | – | – | 1,239 |
| Patrice Eadon Bonfiglio Director | Apr 18, 2026 | Tax withholding | −403 | $14.98 | $6.04K | 836 |
| Keith Horn Director | Apr 18, 2026 | Option exercise | +838 | – | – | 1,239 |
| Keith Horn Director | Apr 18, 2026 | Tax withholding | −403 | $14.98 | $6.04K | 836 |
| Kostas D. Odysseas Director | Apr 18, 2026 | Option exercise | +838 | – | – | 1,239 |
| Kostas D. Odysseas Director | Apr 18, 2026 | Tax withholding | −403 | $14.98 | $6.04K | 836 |
| Louis Sterling III Director | Apr 18, 2026 | Tax withholding | −403 | $14.98 | $6.04K | 4,049 |
| Louis Sterling III Director | Apr 18, 2026 | Option exercise | +838 | – | – | 4,452 |
| Paul Cohen Director | Apr 18, 2026 | Option exercise | +838 | – | – | 1,239 |
| Paul Cohen Director | Apr 18, 2026 | Tax withholding | −403 | $14.98 | $6.04K | 836 |
| Oliver O'Connor Director | Apr 18, 2026 | Option exercise | +838 | – | – | 1,239 |
| Oliver O'Connor Director | Apr 18, 2026 | Tax withholding | −438 | $14.98 | $6.56K | 801 |
| Diane E. Sullivan Director | Apr 18, 2026 | Tax withholding | −403 | $14.98 | $6.04K | 836 |
| Diane E. Sullivan Director | Apr 18, 2026 | Option exercise | +838 | – | – | 1,239 |
| Peter L. Fishman SVP, CFO | Apr 1, 2026 | Option exercise | +125 | – | – | 6,282 |
| Peter L. Fishman SVP, CFO | Apr 1, 2026 | Tax withholding | −62 | $14.46 | $897 | 6,220 |
| Steven B. Ketchum EVP, Chief Scientific Officer | Jan 31, 2026 | Tax withholding | −1,062 | $15.42 | $16.38K | 40,879 |
| Steven B. Ketchum EVP, Chief Scientific Officer | Jan 31, 2026 | Tax withholding | −1,235 | $15.42 | $19.04K | 40,008 |
| Steven B. Ketchum EVP, Chief Scientific Officer | Jan 31, 2026 | Option exercise | +2,246 | – | – | 41,243 |
| Steven B. Ketchum EVP, Chief Scientific Officer | Jan 31, 2026 | Option exercise | +1,933 | – | – | 41,941 |
| Peter L. Fishman SVP, CFO | Jan 31, 2026 | Tax withholding | −1,008 | $15.42 | $15.54K | 6,157 |
| Peter L. Fishman SVP, CFO | Jan 31, 2026 | Tax withholding | −310 | $15.42 | $4.78K | 5,332 |
| Peter L. Fishman SVP, CFO | Jan 31, 2026 | Option exercise | +1,833 | – | – | 7,165 |
| Peter L. Fishman SVP, CFO | Jan 31, 2026 | Option exercise | +563 | – | – | 5,642 |
| David Paul Keenan EVP, Chief Operating Officer | Jan 31, 2026 | Option exercise | +2,246 | – | – | 11,958 |
| David Paul Keenan EVP, Chief Operating Officer | Jan 31, 2026 | Tax withholding | −1,173 | $15.42 | $18.09K | 10,785 |
| David Paul Keenan EVP, Chief Operating Officer | Jan 31, 2026 | Option exercise | +1,933 | – | – | 12,718 |
| David Paul Keenan EVP, Chief Operating Officer | Jan 31, 2026 | Tax withholding | −1,010 | $15.42 | $15.57K | 11,708 |
| Aaron Berg President and CEO | Jan 31, 2026 | Option exercise | +1,933 | – | – | 83,658 |
| Aaron Berg President and CEO | Jan 31, 2026 | Tax withholding | −1,063 | $15.42 | $16.39K | 82,595 |
| Aaron Berg President and CEO | Jan 31, 2026 | Tax withholding | −1,235 | $15.42 | $19.04K | 81,725 |
| Aaron Berg President and CEO | Jan 31, 2026 | Option exercise | +2,246 | – | – | 82,960 |
| Peter L. Fishman SVP, CFO | Jan 2, 2026 | Tax withholding | −1,356 | $13.96 | $18.93K | 5,079 |
| Peter L. Fishman SVP, CFO | Jan 2, 2026 | Option exercise | +2,447 | – | – | 6,435 |
| David Paul Keenan EVP, Chief Operating Officer | Jan 2, 2026 | Option exercise | +3,688 | – | – | 11,638 |
| David Paul Keenan EVP, Chief Operating Officer | Jan 2, 2026 | Tax withholding | −1,926 | $13.96 | $26.89K | 9,712 |
| Steven B. Ketchum EVP, Chief Scientific Officer | Jan 2, 2026 | Tax withholding | −2,041 | $13.96 | $28.49K | 38,997 |
| Steven B. Ketchum EVP, Chief Scientific Officer | Jan 2, 2026 | Option exercise | +3,688 | – | – | 41,038 |
| Jonathan Provoost EVP, Chief Legal Officer | Jan 2, 2026 | Option exercise | +3,688 | – | – | 3,688 |
| Jonathan Provoost EVP, Chief Legal Officer | Jan 2, 2026 | Tax withholding | −1,488 | $13.96 | $20.77K | 2,200 |
| Peter L. Fishman SVP, CFO | Aug 1, 2025 | Tax withholding | −160 | $14.52 | $2.32K | 3,988 |
| Peter L. Fishman SVP, CFO | Aug 1, 2025 | Option exercise | +312 | – | – | 4,148 |
| Aaron Berg President and CEO | Jun 26, 2025 | Tax withholding | −38,363 | $15.90 | $609.97K | 80,714 |
| Aaron Berg President and CEO | Jun 26, 2025 | Option exercise | +75,000 | – | – | 119,077 |
| Paul Cohen Director | Apr 18, 2025 | Option exercise | +838 | – | – | 838 |
| Paul Cohen Director | Apr 18, 2025 | Tax withholding | −437 | $9.11 | $3.98K | 401 |
| Keith Horn Director | Apr 18, 2025 | Option exercise | +838 | – | – | 838 |
| Keith Horn Director | Apr 18, 2025 | Tax withholding | −437 | $9.11 | $3.98K | 401 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| B. Ketchum Steven Officer | Dec 12, 2023 | 34,131 | $28.56K | Dec 12, 2023 | Restricted Stock Units |